Study Purpose: This research aims to understand how anti-cancer drugs work in solid tumors using a tool called the CIVO device, which injects tiny amounts directly into the tumor.
CIVO Device: The CIVO device injects very small doses of up to eight different cancer drugs into the tumor. It uses special markers to show where the drugs were injected, helping doctors see how the tumor reacts when it's removed during scheduled surgery.
Key Aspects:
- Study Duration: Participants will undergo surgery 4 hours to 7 days after the injection.
- Participation Requirements: Must be 18 or older with a surface-accessible solid tumor and agree to the study's schedule.
- Safety Measures: Tumors close to critical structures or those causing risks are not eligible.
Eligibility: To join, you need to be willing to follow the study rules, sign a consent form, and have a tumor that can be accessed by the CIVO device. Women must use effective birth control or be unable to have children, and men must use barrier methods or abstain from sexual activity.